Article Information
History
- March 24, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sivan Gazit, MD, MA1,2,*,
- Yaki Saciuk, MPH MA1,
- Galit Perez, MN MA2,
- Asaf Peretz, MD3,
- Virginia E. Pitzer, ScD3 and
- Tal Patalon, MD1,2
- 1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
- 2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Israel
- 3Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University; New Haven, CT USA
- ↵*Corresponding author. Correspondence to: Sivan Gazit, gazit_s{at}mac.org.il, 27 HaMared street, Tel Aviv, 68125, Israel
Posted March 24, 2022.
Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
58
Blogs/Media
Author Videos